• 제목/요약/키워드: Pulmonary surfactant

검색결과 65건 처리시간 0.019초

흰쥐에서 내독소로 유도된 급성폐손상에서 surfactant내 PAF의 역할 (PAF in Pulmonary Surfactant Contributes to Neutrophilic Oxidative Stress-Induced Acute Lung Injury of Rats Given LPS Intratracheally)

  • 이영만
    • 생명과학회지
    • /
    • 제22권10호
    • /
    • pp.1352-1358
    • /
    • 2012
  • 흰쥐에서 대장균(E.coli : E0127;B8)의 내독소(lipopolysaccharide)로 급성 폐손상을 유도하고 이때 폐장 내 호중구성 respiratory burst에 따른 폐장조직의 변화 및 폐포 내로의 단백질 유출을 확인하였다. Pulmonary surfactant를 분리하고 이때 surfactant대사의 변화와 surfactant내의 PAF함량이 증가한 사실도 확인하였다. Surfactant내의 PAF함량의 증가는 폐포 내로의 호중구의 이동 및 그에 따른 산소기 생성의 증가로 폐장 내의 모세혈관 및 제1형 폐포세포의 직접적 손상의 원인으로 생각되었고, 이러한 surfactant내의 PAF의 증가가 실질적으로 급성 폐손상의 치료를 어렵게 하는 원인의 하나로 생각되었다.

성인성 호흡곤란 증후군에 있어서 Surfactant 치료 (Surfactant Replcement Therapy in Adult Respiratory Distress Syndrome)

  • 박성수;이정희
    • Tuberculosis and Respiratory Diseases
    • /
    • 제40권2호
    • /
    • pp.91-97
    • /
    • 1993
  • Pulmonary surfactant is a lipoprotein complex composed primarily of phospholipid and lung specific apoproteins that reduces surface tension in the alveolus and maintains alveolar stability at low lung volume. Adult respiratory distress syndrome still carries a very high morbidity and mortality. The surfactant system is vital to the maintenance of proper lung function, any type of surfactant deficiency, whether primary or secondary, will contribute significantly to the development of pulmonary pathophysiology. Various mechanisms in adult respiratory distress syndrome may be responsible for such alterations in the surfactant system. Surfactant replacement is now an established treatment for neonatal respiratory distress syndrome, reducing both incidence of complications and mortality. With the current knowledge of surfactant physiology and the pathophysiology of the adult respiratory distress syndrome exogenous surfactant treatment or stimulation of endogenous surfactant synthesis and secretion will prove to be beneficial in preventing and treating the adult respiratory distress syndrome. The study of clinical surfactant therapy for adult respiratory distress syndrome is just beginnig and this can be viewed as an area with exciting potential. As soon as surfactant preparations become more widely available trials should begin to define the role of surfactant treatment in the adult respiratory distress syndrome as an adjunct to available treatment techniques.

  • PDF

Genetic risk factors associated with respiratory distress syndrome

  • Jo, Heui Seung
    • Clinical and Experimental Pediatrics
    • /
    • 제57권4호
    • /
    • pp.157-163
    • /
    • 2014
  • Respiratory distress syndrome (RDS) among preterm infants is typically due to a quantitative deficiency of pulmonary surfactant. Aside from the degree of prematurity, diverse environmental and genetic factors can affect the development of RDS. The variance of the risk of RDS in various races/ethnicities or monozygotic/dizygotic twins has suggested genetic influences on this disorder. So far, several specific mutations in genes encoding surfactant-associated molecules have confirmed this. Specific genetic variants contributing to the regulation of pulmonary development, its structure and function, or the inflammatory response could be candidate risk factors for the development of RDS. This review summarizes the background that suggests the genetic predisposition of RDS, the identified mutations, and candidate genetic polymorphisms of pulmonary surfactant proteins associated with RDS.

The Change of Secretory Activity of the Alveolar Type ll Cell During Acute Alveolar Injury Induced by N-Nitroso-N-Methylurethane

  • Lee, Young-Man;Bang, In-Sook;Lee, Suck-Kang
    • The Korean Journal of Physiology
    • /
    • 제28권1호
    • /
    • pp.71-77
    • /
    • 1994
  • In the animal model of acute respiratory distress syndrome (ARDS) induced by N-nitroso-N-methylurethane (NNNMU) the secretory activity of alveolar type H cells during acute alveolar injury was investigated by determining phospholipid and pulmonary surfactant associated proteins in crude surfactant. The mechanism of the secretory change was studied by determination of DNA and RNA levels in the lung tissue. After induction of acute alveolar injury with NNNMU, pulmonary hemorrhage, atelectasis and gross hypertrophy were observed. Seven days after NNNMU treatment the level of total DNA in lung homogenate was increased markedly indicating that a hypertrophy was induced by cellular proliferation. Although the total DNA level increased, the RNA/DNA ratio was gradually decreased after NNNMU treatment. Seven days after NNNMU treatment the RNA/DNA ratio returned to the normal control level. During the acute alveolar injury, phospholipid and surfactant associated proteins were reduced significantly as compared with the control, implying that the secretory activity of alveolar type II cells was altered during acute alveolar injury induced by NNNMU. The protein content in crude surfactant during peak injury(7 days after NNNMU) was decreased significantly but phospholipid/protein ratios were identical in both control and NNNMU treatment groups. SDS-PAGE of proteins in crude pulmonary surfactant showed a decrease in major surfactant associated protein(M.W. 38,000) during acute alveolar injury. The present study may suggest that while alveolar type H cells proliferate markedly, transcription of alveolar type ll cell gene was inhibited by an unknown mechanism such as DNA methylation induced by NNNMU. Such an inhibition of transcriptional activity is thought to be associated with the decreased secretory activity of alveolar type ll cells, which may lead to pulmonary atelectasis and edema during the acute alveolar injury.

  • PDF

Surfactant-Associated Proteins의 유전인자 발현 (Gene Expression of Surfactant-Associated Proteins)

  • 박성수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제38권3호
    • /
    • pp.228-235
    • /
    • 1991
  • Pulmonary surfactant is a lipoprotein complex composed primarily of phospholipid and lungspecific apoproteins that reduces surface tension in the alveolus and maintains alveolar stability at low lung volume. Three families of lung-specific apoproteins have been described: SP-A, a glycoprotein with a reduced molecular weight of 28~36 KDa. SP-B a hydrophobic protein with a nonreduced molecular weight of 18 KDa, and SP-C a hydrophobic protein with a non-reduced molecular weight of 5~8 KDa. Surfactant proteins have important roles in regulating surfactant metabolism as well as in determining its physical properties. The synthesis of the active surfactant peptides appears to be modulated by system with considerable complexity, including numerous levels of regulation such as cell-specific, hormonal and developmental controls. Endotoxin appears to alter surfactant protein mRNAs differentially. It is hoped that the elucidation of the factors controlling the synthesis and metabolism of the surfactant proteins will aid in understanding the pathogenesis of hyaline membrane disease and offer new avenues for the therapy and diagnosis of ther pulmonary disorders as well.

  • PDF

인터루킨-1$\alpha$를 기관지 투입 후 나타난 폐세척액에서의 대식세포의 미세구조적 변화 (Ultrastructure of Macrophages in BAL of Rat Given Interleukin-1$\alpha$ Intratracheally)

  • 조현국;이영만;박원학
    • 대한의생명과학회지
    • /
    • 제2권2호
    • /
    • pp.159-166
    • /
    • 1996
  • 인터루킨-1을 횐쥐의 기관지 내로 투여하였을 때 급성 부종성 폐손상(acute edematous lung injury)이 유발되며, 폐세척액 내 호중구가 증가되고 surfactant의 양도 증가한다. 대식세포는 증가된 surfactant 기인한 탐식작용 활동이 증가하여 세포 내 환상의 구조물들이 증가하나 정상군과 비교하여 형태적으로 세포기관의 구조에서 차이를 보이고 있다. 이러한 세포구성은 세포간 기능상 의 차이를 나타내는 것이며, surfactant의 순환과 연관성이 있을 것으로 사료된다. 본 연구에서 정상 군에 있어서 폐포강 내 대식세포가 환상의 구조물들을 합성하는 형태를 보였으며, 이것은 surfactant의 재합성과 분비작용과 매우 밀접한 연관성이 있음을 보여 주는 것이다.

  • PDF

일측폐장절제가토에 있어서 steroid가 제 II 형 폐포세포의 기능에 미치는 영향 (Effect of Betamethasone on Pulmonary Surfactant Activity in Unilateral Pneumonectomized Rabbits)

  • 이석강;이영만
    • Journal of Yeungnam Medical Science
    • /
    • 제1권1호
    • /
    • pp.59-66
    • /
    • 1984
  • 일측폐장을 절제한 뒤 대상성증식기의 폐장을 태아폐장증식의 모델로 삼고 이때 steroid가 대상성증식중의 폐장내 제II형폐포세포의 폐포표면활성물질의 분비에 미치는 영향을 알아보기 위한 본 실험의 결과를 요약하면 다음과 같다. 1. 잔류폐장의 무게 및 체중에 대한 폐장무게의 비는 폐절제후 betamethasone을 투여한 군에서 폐절제군에 비해 감소하는 경향을 보였다. 2. 폐세척액내의 인지질인의 함량은 폐절제후 betamethasone을 투여한 군에 있어서는 무처치대조군에 비해서는 유의한(p<0.01) 증가를 보였고 폐절제군에 비해서는 증가하는 경향을 보였다. 3. TLC(thin layer chromatography)를 통해 폐세척액내의 인지질의 조성을 조사한 결과, 폐절제후 betamethasone을 투여한 군은 무처치대조군 및 폐절제군과는 다른 양상을 보였다. 이상의 실험결과로 미루어 steroid는 태아폐장의 대상성증식기에 폐포표면활성물질의 분비를 증가시키며 동시에 제II형폐포세포에서 분비되는 폐포표면활성물질의 주성분인 인지질의 조성에도 변화를 일으켜 폐장의 융압률을 증가시킨다고 사료된다.

  • PDF

신생아 호흡곤란증후군에서 인공 폐 표면활성제 조기요법의 중요성과 필요성 (The Importance and the Need of Early Pulmonary Surfactant Therapy in Premature Infant with Respiratory Distress Syndrome)

  • 김성미;윤혜선;김기수;배종우
    • Neonatal Medicine
    • /
    • 제16권2호
    • /
    • pp.101-109
    • /
    • 2009
  • Pulmonary surfactant (PS) therapy in premature infants has a remarkable impact on improving survival and outcomes in neonatal respiratory distress syndrome (RDS). Early PS therapy involves instillation of PS upon delivery of very premature infants or if there is evidence of RDS, such as an increased requirement of oxygen 2 hours after birth, especially in infants <30 weeks gestation. Early PS treatment in very premature infants results in a significant reduction in the severity of RDS, mortality, and incidence of pneumothorax, pulmonary interstitial emphysema, and bronchopulmonary dysplasia in comparison with late PS treatment. According to European and American consensus guidelines on the management of neonatal RDS, early PS instillation should be considered for infants <30 weeks gestation, infants with a birth weight <1,250 g, or if the mother has not received antepartum corticosteroids. We suggest that the Korean health insurance policy on RDS be modified so that PS can be used for better clinical outcomes of very premature infants.

재팽창성 폐부종 (Reexpansion Pulmonary Edema)

  • 지청현
    • Journal of Chest Surgery
    • /
    • 제24권8호
    • /
    • pp.797-801
    • /
    • 1991
  • Reexpansion pulmonary edema following pneumothorax, atelectasis, massive pleural effusion are clinically uncommon, but sometimes life threatening progression. Reexpansion pulmonary edema is usually ipsilateral but rarely contralateral or both. Reexpansion pulmonary edema was occurred when chronically collapsed lung is rapidly reexpanded by evacuation of large amounts of air or fluid. The pathogenesis of the reexpansion pulmonary edema is unknown but is probably mutifactorial. The etiological factors of the reexpansion pulmonary edema are chronicity of the lung collapse, technique of the reexpansion, airway obstruction, loss of the surfactant, and pulmonary artery pressure changes. In the treatment of the chronically collapsed lung, physician must be remembered the possible events, and to prevent of the complication.

  • PDF

Effect of Maternal Selenium Nutrition on pulmonary Selenium, Glutathione Peroxidase, and Phospholipid Levels in Neonatal Rats

  • Kim, Hye-Yung
    • Journal of Nutrition and Health
    • /
    • 제27권9호
    • /
    • pp.940-948
    • /
    • 1994
  • The present study was designed to determine if prenatal and postnatal Se nutriture affects Se concentration, glutathione peroxidase(GSHPx) activity and phospholipid distribution of the neonatal rat lung. Female SD rats were bred and fed a semipurified Se-deficient(0.04ppm, Se-) or a Se-adequate(0.5ppm, Se+) diet through pregnancy and lactation. On d 2 of lactation, maternal dietary Se had no significant effect on pulmonary Se concentration of pups. On d 16 of lactation, mean milk Se concentration in Se- dams was significantly lower than that in Se+ dams. Milk Se concentration was reflected on lung Se concentration and GSHPx activity of d 16 pups, which were dramatically decreased in Se- pups. In addition, pulmonary disaturated phosphatidyl choline/total phosphatidyl choline ratio was also significantly decreased in Se- pups, implying impaired function of pulmonary surfactant. These data indicate that adequate Se nutrition is important in the maturation of neonatal rat lungs.

  • PDF